These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33611657)

  • 1. COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review.
    Nas K; Eryilmaz N; Geyik MF; Altaş A
    Rheumatol Int; 2021 Apr; 41(4):811-817. PubMed ID: 33611657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of COVID-19 on familial Mediterranean fever: a nationwide study.
    Günendi Z; Yurdakul FG; Bodur H; Cengiz AK; Uçar Ü; Çay HF; Şen N; Keskin Y; Gürer G; Melikoğlu MA; Altıntaş D; Deveci H; Baykul M; Nas K; Çevik R; Karahan AY; Toprak M; Ketenci S; Nayimoğlu M; Sezer İ; Demir AN; Ecesoy H; Duruöz MT; Yurdakul OV; Sarıfakıoğlu AB; Ataman Ş
    Rheumatol Int; 2021 Aug; 41(8):1447-1455. PubMed ID: 34032894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course of COVID-19 infection in paediatric familial Mediterranean fever patients.
    Kaya Akca U; Sener S; Balık Z; Gurlevik S; Oygar PD; Atalay E; Cuceoglu MK; Basaran O; Batu ED; Teksam O; Bilginer Y; Ozsurekci Y; Ozen S
    Mod Rheumatol; 2022 Feb; 32(2):467-472. PubMed ID: 34897503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [INTERLEUKIN 1 INHIBITORS--A NEW HORIZON IN THE TREATMENT OF FAMILIAL MEDITERRANEAN FEVER].
    Shouval R; Livneh A; Ben-Zvi I
    Harefuah; 2015 Nov; 154(11):716-9, 741. PubMed ID: 26821505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial Mediterranean Fever and COVID-19: Friends or Foes?
    Stella A; Lamkanfi M; Portincasa P
    Front Immunol; 2020; 11():574593. PubMed ID: 33072117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact and disease evolution of SARS-CoV-2 infection in familial Mediterranean fever.
    Marinelli F; Caporilli C; Titolo A; Rigante D; Esposito S
    Pharmacol Res; 2022 Aug; 182():106293. PubMed ID: 35690330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and course of COVID-19 hospitalizations among patients with familial Mediterranean fever.
    Kharouf F; Ishay Y; Kenig A; Bitan M; Ben-Chetrit E
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI85-SI89. PubMed ID: 34293118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease.
    Avanoglu Guler A; Yuce Inel T; Kasifoglu T; Coskun C; Karadeniz H; Yildirim D; Bilici R; Satis H; Kucuk H; Haznedaroglu S; Goker B; Ozturk MA; Sari I; Tufan A
    Mod Rheumatol; 2023 Jul; 33(4):786-791. PubMed ID: 35860978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approach to the patients with inadequate response to colchicine in familial Mediterranean fever.
    Gül A
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):296-303. PubMed ID: 27886801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study.
    Güven SC; Erden A; Karakaş Ö; Armağan B; Usul E; Omma A; Küçükşahin O
    Rheumatol Int; 2021 Apr; 41(4):715-719. PubMed ID: 33611656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 in patients with gout on colchicine.
    Pelechas E; Drossou V; Voulgari PV; Drosos AA
    Rheumatol Int; 2021 Aug; 41(8):1503-1507. PubMed ID: 34089357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
    Kurt T; Aydın F; Nilüfer Tekgöz P; Sezer M; Uncu N; Çelikel Acar B
    Int J Rheum Dis; 2020 Jul; 23(7):977-981. PubMed ID: 32558310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.
    Kucuksahin O; Yildizgoren MT; Ilgen U; Ates A; Kinikli G; Turgay M; Erten S
    Mod Rheumatol; 2017 Mar; 27(2):350-355. PubMed ID: 27328763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological agents in familial Mediterranean fever focusing on colchicine resistance and amyloidosis.
    Sozeri B; Kasapcopur O
    Curr Med Chem; 2015; 22(16):1986-91. PubMed ID: 25760087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever.
    Corsia A; Georgin-Lavialle S; Hentgen V; Hachulla E; Grateau G; Faye A; Quartier P; Rossi-Semerano L; Koné-Paut I
    Orphanet J Rare Dis; 2017 Mar; 12(1):54. PubMed ID: 28302131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis.
    Sargin G; Kose R; Senturk T
    Sao Paulo Med J; 2019 May; 137(1):39-44. PubMed ID: 31116269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.
    Portincasa P; Scaccianoce G; Palasciano G
    Eur J Clin Invest; 2013 Dec; 43(12):1314-27. PubMed ID: 24117178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
    Şahin A; Derin ME; Albayrak F; Karakaş B; Karagöz Y
    Adv Rheumatol; 2020 Jan; 60(1):12. PubMed ID: 32000860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
    Koga T; Sato S; Miyamoto J; Hagimori N; Kawazoe Y; Arinaga K; Fukushima C; Yamamoto H; Kawakami A
    Trials; 2018 Dec; 19(1):715. PubMed ID: 30594222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic.
    Haslak F; Yildiz M; Adrovic A; Sahin S; Koker O; Aliyeva A; Barut K; Kasapcopur O
    Rheumatol Int; 2020 Sep; 40(9):1423-1431. PubMed ID: 32661928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.